Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Research output: Contribution to journal › Article › Academic › peer-review

2901 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2097-2107
Number of pages	11
Journal	New England Journal of Medicine
Volume	379
Issue number	22
DOIs	https://doi.org/10.1056/NEJMoa1801174
Publication status	Published - 2018

Research programs

@article{fa0593d4795440b382e36b57672a4b75,

title = "Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome",

author = "GG Schwartz and PG Steg and M Szarek and E.J.G. Sijbrands and VA Bittner and R Diaz",

year = "2018",

doi = "10.1056/NEJMoa1801174",

language = "Undefined/Unknown",

volume = "379",

pages = "2097--2107",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "22",

}

TY - JOUR

T1 - Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

AU - Schwartz, GG

AU - Steg, PG

AU - Szarek, M

AU - Sijbrands, E.J.G.

AU - Bittner, VA

AU - Diaz, R

PY - 2018

Y1 - 2018

U2 - 10.1056/NEJMoa1801174

DO - 10.1056/NEJMoa1801174

M3 - Article

C2 - 30403574

SN - 0028-4793

VL - 379

SP - 2097

EP - 2107

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 22

ER -